Crixivan Articles
Ritonavir Cuts HIV Deaths By Almost Half, Says Study
12 February 1996
Triple Therapies For HIV Provide Encouraging Data
5 February 1996
Agouron Pushes Viracept Towards Pivotal Trials
15 January 1996
Winners And Losers In US Medicare/Medicaid Reform
20 November 1995
New Phase II Data On Merck & Co's Crixivan
9 October 1995
Merck's Crixivan: new study data
2 October 1995
Expanded Access For Merck's Crixivan
24 July 1995
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Elan makes "transformational" acquisitions and a divestment
